All Stories

  1. Tfh2 and a subset of Tfh1 cells associate with antibody-mediated immunity to malaria

    Article • JCI Insight, October 2025, American Society for Clinical Investigation

    James Beeson

  2. Evaluation of whole blood CD64 for identifying infection in neonates receiving hospital care

    Article • Frontiers in Immunology, August 2025, Frontiers

    James Beeson

  3. An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies

    Article • July 2025, eLife

    James Beeson

  4. Development of high affinity antibodies to Plasmodium falciparum merozoite and sporozoite antigens during infancy and adulthood

    Article • Frontiers in Immunology, July 2025, Frontiers

    James Beeson

  5. Role of malaria exposure and off-target responses on RTS,S/AS02A vaccine immunogenicity and protection in Mozambican children

    Article • npj Vaccines, June 2025, Springer Science + Business Media

    James Beeson

  6. Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections

    Article • Journal of Infection, April 2025, Elsevier

    Dr Josep Vidal-Alaball, James Beeson

  7. Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion

    Article • Frontiers in Immunology, March 2025, Frontiers

    James Beeson

  8. Antibody correlates of risk of clinical malaria in an area of low and unstable malaria transmission in western Kenya

    Article • Malaria Journal, March 2025, Springer Science + Business Media

    James Beeson

  9. Functionally Distinct pTfh1 Subsets with Roles in Malaria-Specific Immunity

    Article • March 2025, openRxiv

    James Beeson

  10. Antimicrobials for Neonates: Practitioner Decisions and Diagnostic Certainty

    Article • The Pediatric Infectious Disease Journal, February 2025, Wolters Kluwer Health

    James Beeson

  11. Detrimental infant and maternal outcomes of undiagnosed asymptomatic malaria in pregnancy

    Article • PLoS Medicine, February 2025, PLOS

    James Beeson

  12. IgM Is Prominent and Activates Complement in Acquired Transmission-Blocking Immunity Against Malaria

    Article • January 2025, Elsevier

    James Beeson

  13. Women's Perspectives on Health Service Integration Inform Strategies to Address Multi-Morbidity in Pregnancy, Childbirth and Postpartum in a High Burden Setting

    Article • January 2025, Elsevier

    James Beeson

  14. Induction of Fc-dependent functional antibodies against different variants of SARS-CoV-2 varies by vaccine type and prior infection

    Article • Communications Medicine, December 2024, Springer Science + Business Media

    James Beeson

  15. Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages

    Article • Nature Communications, December 2024, Springer Science + Business Media

    James Beeson

  16. Integrated Approaches for the Delivery of Maternal and Child Health Services with Childhood Immunization Programs in Low- and Middle-Income Countries: Systematic Review Update 2011–2020

    Article • Vaccines, November 2024, MDPI AG

    James Beeson

  17. Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infection

    Article • EBioMedicine, November 2024, Elsevier

    James Beeson

  18. Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial

    Article • The Lancet Microbe, October 2024, Elsevier

    James Beeson

  19. Mycoplasma genitalium in pregnancy, including specific co-infections, is associated with lower birthweight: A prospective cohort study

    Article • Med, September 2024, Elsevier

    James Beeson

  20. A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

    Article • Nature Communications, August 2024, Springer Science + Business Media

    James Beeson

  21. IgM plays a prominent role in naturally acquired immunity against Plasmodium falciparum gametocytes

    Article • July 2024, openRxiv

    James Beeson

  22. Geospatial joint modeling of vector and parasite serology to microstratify malaria transmission

    Article • Proceedings of the National Academy of Sciences, June 2024, Proceedings of the National Academy of Sciences

    Freya Fowkes, James Beeson

  23. Declining Antibody Affinity Over Time After Human Vaccination With a Plasmodium falciparum Merozoite Vaccine Candidate

    Article • The Journal of Infectious Diseases, May 2024, Oxford University Press (OUP)

    James Beeson

  24. Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infection

    Article • April 2024, openRxiv

    James Beeson

  25. Previous Malaria Exposures and Immune Dysregulation: Developing Strategies To Improve Malaria Vaccine Efficacy in Young Children

    Article • American Journal of Tropical Medicine and Hygiene, April 2024, American Society of Tropical Medicine and Hygiene

    James Beeson

  26. A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies

    Article • Vaccine, March 2024, Elsevier

    James Beeson

  27. Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages

    Article • February 2024, openRxiv

    James Beeson

  28. Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages

    Article • February 2024, Springer Science + Business Media

    James Beeson

  29. Clinical and immunological outcomes of HIV-exposed uninfected and HIV-unexposed uninfected children in the first 24 months of life in Western Kenya

    Article • BMC Infectious Diseases, February 2024, Springer Science + Business Media

    James Beeson

  30. Complement detection on trophozoite stage Plasmodium falciparumparasites using flow cytometry or Western blot

    Article • January 2024, Springer Science + Business Media

    James Beeson

  31. Plasmodium falciparum Growth or Invasion Inhibition Assays

    Article • January 2024, Springer Science + Business Media

    James Beeson

  32. Antibody-dependent cell-mediated cytotoxicity (ADCC) assay with natural killer cells in malaria immunity

    Article • January 2024, Springer Science + Business Media

    James Beeson

  33. Complement-fixation by antibodies to Plasmodium falciparum

    Article • January 2024, Springer Science + Business Media

    James Beeson

  34. Isolation of viable Plasmodium falciparum merozoites

    Article • January 2024, Springer Science + Business Media

    James Beeson

  35. Phagocytosis of antigen-coated beads or malaria parasites using neutrophils

    Article • January 2024, Springer Science + Business Media

    James Beeson

  36. Quantifying antibody binding to Fcγ-receptors in malaria immunity

    Article • January 2024, Springer Science + Business Media

    James Beeson

  37. Acquisition of complement fixing antibodies targeting Plasmodium falciparum merozoites in infants and their mothers in Uganda

    Article • Frontiers in Immunology, November 2023, Frontiers

    James Beeson

  38. A step forward for Plasmodium falciparum malaria transmission-blocking vaccines

    Article • The Lancet Infectious Diseases, November 2023, Elsevier

    James Beeson

  39. Fc-dependent functional activity of ChAdOx1-S and CoronaVac vaccine-induced antibodies to the SARS-CoV-2 spike protein

    Article • October 2023, openRxiv

    James Beeson

  40. Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso

    Article • Infection and Immunity, October 2023, ASM Journals

    James Beeson

  41. Community perspectives and experiences of quality maternal and newborn care in East New Britain, Papua New Guinea

    Article • BMC Health Services Research, July 2023, Springer Science + Business Media

    James Beeson

  42. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019

    Article • The Lancet, July 2023, Elsevier

    Sandra Barteit, Dr Ali Fatehizadeh, Prof Tommi Vasankari, Musa Ali, Dr Mohammad Hosein Amirzade-Iranaq, Dr Jessica A Kerr, Prince Peprah, Alexander Mathioudakis, Natália Cruz-Martins, Dr Fakher Rahim, James Beeson

  43. Quantifying differences in iron deficiency-attributable anemia during pregnancy and postpartum

    Article • Cell Reports Medicine, July 2023, Elsevier

    James Beeson

  44. Clinical and Immunological Outcomes of HIV-Exposed Uninfected and HIV-Unexposed Uninfected Children in the First 24 Months of Life in Western Kenya

    Article • June 2023, Research Square

    James Beeson

  45. Antibody to Plasmodium falciparum Variant Surface Antigens, var Gene Transcription, and ABO Blood Group in Children With Severe or Uncomplicated Malaria

    Article • The Journal of Infectious Diseases, June 2023, Oxford University Press (OUP)

    James Beeson

  46. Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis

    Article • Journal of Thrombosis and Thrombolysis, April 2023, Springer Science + Business Media

    James Beeson

  47. Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines

    Article • Cellular and Molecular Life Sciences, February 2023, Springer Science + Business Media

    James Beeson

  48. Low knowledge of newborn danger signs among pregnant women in Papua New Guinea and implications for health seeking behaviour in early infancy – findings from a longitudinal study

    Article • BMC Pregnancy and Childbirth, January 2023, Springer Science + Business Media

    James Beeson

  49. Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

    Article • Frontiers in Immunology, January 2023, Frontiers

    James Beeson

  50. The direct binding of Plasmodium vivax AMA1 to erythrocytes defines a RON2-independent invasion pathway

    Article • Proceedings of the National Academy of Sciences, December 2022, Proceedings of the National Academy of Sciences

    James Beeson

  51. Targeting malaria parasites with novel derivatives of azithromycin

    Article • Frontiers in Cellular and Infection Microbiology, November 2022, Frontiers

    A/Prof Rietie Venter, Dr Brad E Sleebs, James Beeson

  52. The RTS,S malaria vaccine: Current impact and foundation for the future

    Article • Science Translational Medicine, November 2022, American Association for the Advancement of Science

    James Beeson

  53. Asia-Pacific ICEMR: Understanding Malaria Transmission to Accelerate Malaria Elimination in the Asia Pacific Region

    Article • American Journal of Tropical Medicine and Hygiene, October 2022, American Society of Tropical Medicine and Hygiene

    James Beeson

  54. Impact of Environmental Modifications on the Ecology, Epidemiology, and Pathogenesis of Plasmodium falciparum and Plasmodium vivax Malaria in East Africa

    Article • American Journal of Tropical Medicine and Hygiene, October 2022, American Society of Tropical Medicine and Hygiene

    James Beeson

  55. Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children

    Article • BMC Medicine, August 2022, Springer Science + Business Media

    James Beeson

  56. Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes

    Article • Nature Genetics, August 2022, Springer Science + Business Media

    James Beeson

  57. Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate–high malaria transmission intensity

    Article • Frontiers in Cellular and Infection Microbiology, August 2022, Frontiers

    James Beeson

  58. Author Correction: Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique

    Article • npj Vaccines, August 2022, Springer Science + Business Media

    James Beeson

  59. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

    Article • Frontiers in Immunology, July 2022, Frontiers

    James Beeson

  60. Antibody dynamics in children with first or repeat Plasmodium falciparum infections

    Article • Frontiers in Medicine, July 2022, Frontiers

    James Beeson

  61. Age-dependent changes in circulating Tfh cells influence development of functional malaria antibodies in children

    Article • Nature Communications, July 2022, Springer Science + Business Media

    James Beeson

  62. Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia

    Article • The Journal of Infectious Diseases, June 2022, Oxford University Press (OUP)

    James Beeson

  63. Quality newborn care in East New Britain, Papua New Guinea: measuring early newborn care practices and identifying opportunities for improvement

    Article • BMC Pregnancy and Childbirth, June 2022, Springer Science + Business Media

    James Beeson

  64. Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children

    Article • May 2022, Cold Spring Harbor Laboratory Press

    James Beeson

  65. The Plasmodium falciparum parasitophorous vacuole protein P113 interacts with the parasite protein export machinery and maintains normal vacuole architecture

    Article • Molecular Microbiology, April 2022, Wiley

    James Beeson

  66. Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National Study

    Article • Frontiers in Cellular and Infection Microbiology, April 2022, Frontiers

    James Beeson

  67. Quantification of the dynamics of antibody response to malaria to inform sero-surveillance in pregnant women

    Article • Malaria Journal, March 2022, Springer Science + Business Media

    James Beeson

  68. Partnership-defined quality approach to companionship during labour and birth in East New Britain, Papua New Guinea: A mixed-methods study

    Article • PLOS Global Public Health, February 2022, PLOS

    James Beeson

  69. Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children

    Article • EBioMedicine, January 2022, Elsevier

    James Beeson

  70. Age dependent changes in circulating Tfh cells influence the development of functional antibodies to malaria in children.

    Article • December 2021, Springer Science + Business Media

    James Beeson

  71. Age dependent changes in circulating Tfh cells influence the development of functional antibodies to malaria in children

    Article • December 2021, Cold Spring Harbor Laboratory Press

    James Beeson

  72. Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity

    Article • Frontiers in Immunology, December 2021, Frontiers

    James Beeson

  73. Multi-functional antibody profiling for malaria vaccine development and evaluation

    Article • Expert Review of Vaccines, October 2021, Taylor & Francis

    James Beeson

  74. Recent clinical trials inform the future for malaria vaccines

    Article • Communications Medicine, August 2021, Springer Science + Business Media

    James Beeson

  75. Reduced risk of placental parasitemia associated with complement fixation on Plasmodium falciparum by antibodies among pregnant women

    Article • BMC Medicine, August 2021, Springer Science + Business Media

    James Beeson

  76. High Antibodies to VAR2CSA in Response to Malaria Infection Are Associated With Improved Birthweight in a Longitudinal Study of Pregnant Women

    Article • Frontiers in Immunology, June 2021, Frontiers

    James Beeson

  77. Reduced risk of placental parasitaemia associated with complement fixation on Plasmodium falciparum by antibodies among pregnant women

    Article • June 2021, Cold Spring Harbor Laboratory Press

    James Beeson

  78. Community-based molecular and serological surveillance of subclinical malaria in Myanmar

    Article • BMC Medicine, May 2021, Springer Science + Business Media

    James Beeson

  79. HIV infection and placental malaria reduce maternal transfer of multiple antimalarial antibodies in Mozambican women

    Article • Journal of Infection, April 2021, Elsevier

    James Beeson

  80. Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoites

    Article • Nature Communications, March 2021, Springer Science + Business Media

    James Beeson

  81. Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice

    Article • Frontiers in Immunology, March 2021, Frontiers

    James Beeson

  82. Framework for Characterizing Longitudinal Antibody Response in Children After Plasmodium falciparum Infection

    Article • Frontiers in Immunology, March 2021, Frontiers

    James Beeson

  83. Mycoplasma genitalium and Other Reproductive Tract Infections in Pregnant Women, Papua New Guinea, 2015–2017

    Article • Emerging Infectious Diseases, March 2021, Centers for Disease Control and Prevention (CDC)

    James Beeson

  84. Complement Factors in COVID-19 Therapeutics and Vaccines

    Article • Trends in Immunology, February 2021, Elsevier

    James Beeson

  85. Impact of a Rapid Decline in Malaria Transmission on Antimalarial IgG Subclasses and Avidity

    Article • Frontiers in Immunology, January 2021, Frontiers

    James Beeson

  86. Risk factors and knowledge associated with high unintended pregnancy rates and low family planning use among pregnant women in Papua New Guinea

    Article • Scientific Reports, January 2021, Springer Science + Business Media

    James Beeson

  87. RTS,S/AS01E malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial

    Article • Vaccine, January 2021, Elsevier

    James Beeson

  88. Novel virus-like particle vaccine encoding the circumsporozoite protein ofPlasmodium falciparumis immunogenic and induces functional antibody responses

    Article • December 2020, Cold Spring Harbor Laboratory Press

    James Beeson

  89. Th2-like T Follicular Helper Cells Promote Functional Antibody Production during Plasmodium falciparum Infection

    Article • Cell Reports Medicine, December 2020, Elsevier

    James Beeson

  90. Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration

    Article • BMC Medicine, November 2020, Springer Science + Business Media

    James Beeson

  91. Structure‐Activity Studies of Truncated Latrunculin Analogues with Antimalarial Activity

    Article • ChemMedChem, November 2020, Wiley

    James Beeson

  92. Epitope masking may limit antibody boosting to malaria vaccines

    Article • Immunology and Cell Biology, November 2020, Wiley

    James Beeson

  93. Improving the quality of maternal and newborn care in the Pacific region: A scoping review

    Article • The Lancet Regional Health - Western Pacific, October 2020, Elsevier

    James Beeson

  94. Retargeting azithromycin analogues to have dual-modality antimalarial activity

    Article • BMC Biology, September 2020, Springer Science + Business Media

    Dr Brad E Sleebs, James Beeson

  95. Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia

    Article • BMC Medicine, September 2020, Springer Science + Business Media

    James Beeson

  96. Evaluation of the effectiveness of topical repellent distributed by village health volunteer networks against Plasmodium spp. infection in Myanmar: A stepped-wedge cluster randomised trial

    Article • PLoS Medicine, August 2020, PLOS

    Freya Fowkes, James Beeson

  97. Identifying and combating the impacts of COVID-19 on malaria

    Article • BMC Medicine, July 2020, Springer Science + Business Media

    James Beeson

  98. Author Correction: Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique

    Article • npj Vaccines, July 2020, Springer Science + Business Media

    James Beeson

  99. Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia

    Article • July 2020, Cold Spring Harbor Laboratory Press

    James Beeson

  100. Impact of a rapid decline in malaria transmission on antimalarial IgG subclasses and avidity

    Article • June 2020, Cold Spring Harbor Laboratory Press

    James Beeson

  101. Iron Deficiency Is Associated With Reduced Levels of Plasmodium falciparum-specific Antibodies in African Children

    Article • Clinical Infectious Diseases, June 2020, Oxford University Press (OUP)

    James Beeson

  102. Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique

    Article • npj Vaccines, June 2020, Springer Science + Business Media

    James Beeson

  103. High burden ofMycoplasma genitaliumand other reproductive tract infections among pregnant women in Papua New Guinea

    Article • May 2020, Cold Spring Harbor Laboratory Press

    James Beeson

  104. Th2-like T-follicular helper cells promote functional antibody production duringPlasmodium falciparuminfection

    Article • May 2020, Cold Spring Harbor Laboratory Press

    James Beeson

  105. Selection of Antibody Responses Associated With Plasmodium falciparum Infections in the Context of Malaria Elimination

    Article • Frontiers in Immunology, May 2020, Frontiers

    James Beeson

  106. Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration

    Article • April 2020, Cold Spring Harbor Laboratory Press

    James Beeson

  107. Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial

    Article • The Journal of Infectious Diseases, March 2020, Oxford University Press (OUP)

    James Beeson

  108. Strengthening routine immunization in Papua New Guinea: a cross-sectional provincial assessment of front-line services

    Article • BMC Public Health, January 2020, Springer Science + Business Media

    James Beeson

  109. Multi-functional antibodies are induced by the RTS,S malaria vaccine and associated with protection in a phase I/IIa trial

    Article • November 2019, Cold Spring Harbor Laboratory Press

    James Beeson

  110. Strengthening routine immunization in Papua New Guinea: a cross-sectional provincial assessment of front-line services.

    Article • October 2019, Springer Science + Business Media

    James Beeson

  111. Complement in malaria immunity and vaccines

    Article • Immunological Reviews, September 2019, Wiley

    James Beeson

  112. Novel particles for malaria vaccines

    Article • PLOS One, September 2019, PLOS

    James Beeson

  113. IgM in human immunity to Plasmodium falciparum malaria

    Article • Science Advances, September 2019, American Association for the Advancement of Science

    James Beeson

  114. Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha

    Article • PLOS One, September 2019, PLOS

    James Beeson

  115. Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M

    Article • The Journal of Infectious Diseases, August 2019, Oxford University Press (OUP)

    James Beeson

  116. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study

    Article • BMC Medicine, August 2019, Springer Science + Business Media

    James Beeson

  117. Iron deficiency, malaria, and low birth weight.

    Article • BMC Medicine, August 2019, Springer Science + Business Media

    James Beeson

  118. Antibody Reactivity to Merozoite Antigens in Ghanaian Adults Correlates With Growth Inhibitory Activity Against Plasmodium falciparum in Culture

    Article • Open Forum Infectious Diseases, May 2019, Oxford University Press (OUP)

    James Beeson

  119. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives

    Article • The Journal of Infectious Diseases, May 2019, Oxford University Press (OUP)

    James Beeson

  120. Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity

    Article • April 2019, Cold Spring Harbor Laboratory Press

    James Beeson

  121. Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced inHansenula polymorpha

    Article • April 2019, Cold Spring Harbor Laboratory Press

    James Beeson

  122. Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination

    Article • Frontiers in Immunology, March 2019, Frontiers

    James Beeson

  123. Dendritic Cell Responses and Function in Malaria

    Article • Frontiers in Immunology, March 2019, Frontiers

    James Beeson

  124. Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein

    Article • Vaccine, March 2019, Elsevier

    James Beeson

  125. The salt between the beans: a qualitative study of the role of auxiliary midwives in a hard-to-reach area of Myanmar

    Article • BMC Health Services Research, February 2019, Springer Science + Business Media

    James Beeson

  126. Understanding how the RTS,S malaria vaccine works

    Article • BMC Medicine, February 2019, Springer Science + Business Media

    James Beeson

  127. Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection

    Article • Scientific Reports, February 2019, Springer Science + Business Media

    James Beeson

  128. Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination

    Article • Gates Open Research, February 2019, Faculty of 1000, Ltd.

    James Beeson

  129. Targeting malaria parasite invasion of red blood cells as an antimalarial strategy

    Article • FEMS Microbiology Reviews, February 2019, Oxford University Press (OUP)

    James Beeson

  130. Targets of complement-fixing antibodies in protective immunity against malaria

    Article • Nature Communications, February 2019, Springer Science + Business Media

    James Beeson

  131. Different Life Cycle Stages of Plasmodium falciparum Induce Contrasting Responses in Dendritic Cells

    Article • Frontiers in Immunology, January 2019, Frontiers

    James Beeson

  132. The impact of early life exposure to Plasmodium falciparum on the development of naturally acquired immunity to malaria in young Malawian children

    Article • Malaria Journal, January 2019, Springer Science + Business Media

    James Beeson

  133. Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human Plasmodium falciparum Infections

    Article • Frontiers in Microbiology, January 2019, Frontiers

    James Beeson

  134. Understanding transmission-blocking immunity compared to clinical immunity in malaria

    Article • Frontiers in Immunology, January 2019, Frontiers

    James Beeson

  135. Challenges and strategies for developing efficacious and long-lasting malaria vaccines

    Article • Science Translational Medicine, January 2019, American Association for the Advancement of Science

    James Beeson

  136. KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization

    Article • Frontiers in Immunology, December 2018, Frontiers

    James Beeson

  137. Effectiveness of repellent delivered through village health volunteers on malaria incidence in villages in South-East Myanmar: a stepped-wedge cluster-randomised controlled trial protocol

    Article • BMC Infectious Diseases, December 2018, Springer Science + Business Media

    James Beeson

  138. Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia

    Article • JCI Insight, November 2018, American Society for Clinical Investigation

    James Beeson

  139. Acquisition of Antibodies Against Endothelial Protein C Receptor–Binding Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Severe Malaria

    Article • The Journal of Infectious Diseases, October 2018, Oxford University Press (OUP)

    James Beeson

  140. Multiple morbidities in pregnancy: Time for research, innovation, and action

    Article • PLoS Medicine, September 2018, PLOS

    James Beeson

  141. Iron deficiency in pregnancy and poor birth outcomes

    Article • BMC Medicine, September 2018, Springer Science + Business Media

    James Beeson

  142. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial

    Article • PLoS Medicine, July 2018, PLOS

    James Beeson

  143. Cellular dissection of malaria parasite invasion of human erythrocytes using viable Plasmodium knowlesi merozoites

    Article • Scientific Reports, July 2018, Springer Science + Business Media

    James Beeson

  144. Factors influencing the induction of high affinity antibodies to Plasmodium falciparum merozoite antigens and how affinity changes over time

    Article • Scientific Reports, June 2018, Springer Science + Business Media

    James Beeson

  145. Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG1–4, IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies

    Article • Malaria Journal, June 2018, Springer Science + Business Media

    Dr Benoit Gamain, James Beeson

  146. The Complement System Contributes to Functional Antibody-Mediated Responses Induced by Immunization withPlasmodium falciparumMalaria Sporozoites

    Article • Infection and Immunity, May 2018, ASM Journals

    James Beeson

  147. Mechanism of immunity to malaria - blocking sporozoite infection

    Article • BMC Medicine, April 2018, Springer Science + Business Media

    James Beeson

  148. Overcoming antigenic diversity of malaria vaccine candidates for better protection

    Article • The Journal of Infectious Diseases, March 2018, Oxford University Press (OUP)

    James Beeson

  149. Proteome-wide mapping of immune features onto Plasmodium protein three-dimensional structures

    Article • Scientific Reports, March 2018, Springer Science + Business Media

    James Beeson

  150. Combating low birth weight due to malaria infection in pregnancy.

    Article • Science Translational Medicine, March 2018, American Association for the Advancement of Science

    James Beeson

  151. Effect of nutrient supplementation on the acquisition of humoral immunity to Plasmodium falciparum in young Malawian children

    Article • Malaria Journal, February 2018, Springer Science + Business Media

    James Beeson

  152. Establishment of a yeast-based VLP platform for antigen presentation

    Article • Microbial Cell Factories, February 2018, Springer Science + Business Media

    James Beeson

  153. Antibodies generated by a vaccine against malaria in pregnancy

    Article • Parasites & Vectors, January 2018, Springer Science + Business Media

    James Beeson

  154. The potential of task shifting selected maternal interventions to auxiliary midwives in Myanmar: a mixed-method study

    Article • BMC Public Health, January 2018, Springer Science + Business Media

    James Beeson

  155. Immunity to severe malaria in children

    Article • The Journal of Infectious Diseases, January 2018, Oxford University Press (OUP)

    James Beeson

  156. Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya

    Article • Scientific Reports, December 2017, Springer Science + Business Media

    James Beeson

  157. Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development

    Article • The Journal of Infectious Diseases, November 2017, Oxford University Press (OUP)

    James Beeson

  158. Impaired placental autophagy in placental malaria

    Article • PLOS One, November 2017, PLOS

    James Beeson

  159. P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission

    Article • PLOS One, October 2017, PLOS

    Prof Rose McGready, James Beeson

  160. Identifying Immune Correlates of Protection Against Plasmodium falciparum Through a Novel Approach to Account for Heterogeneity in Malaria Exposure

    Article • Clinical Infectious Diseases, September 2017, Oxford University Press (OUP)

    James Beeson

  161. Understanding how immunity to malaria develops in children

    Article • European Journal of Immunology, September 2017, Wiley

    James Beeson

  162. Identifying new drugs against malaria

    Article • Antimicrobial Agents and Chemotherapy, September 2017, ASM Journals

    James Beeson

  163. Acquisition, maintenance and adaptation of invasion inhibitory antibodies against Plasmodium falciparum invasion ligands involved in immune evasion

    Article • PLOS One, August 2017, PLOS

    James Beeson

  164. The establishment of a WHO Reference Reagent for anti-malaria (Plasmodium falciparum) human serum

    Article • Malaria Journal, August 2017, Springer Science + Business Media

    James Beeson

  165. Declining Transmission and Immunity to Malaria and Emerging Artemisinin Resistance in Thailand: A Longitudinal Study

    Article • The Journal of Infectious Diseases, August 2017, Oxford University Press (OUP)

    James Beeson

  166. Dichotomous miR expression and immune responses following primary blood-stage malaria

    Article • JCI Insight, August 2017, American Society for Clinical Investigation

    James Beeson

  167. Impact of declining malaria transmission on human immunity

    Article • The Journal of Infectious Diseases, August 2017, Oxford University Press (OUP)

    James Beeson

  168. The exported chaperone Hsp70-x supports virulence functions for Plasmodium falciparum blood stage parasites

    Article • PLOS One, July 2017, PLOS

    James Beeson

  169. Host age and expression of genes involved in red blood cell invasion in Plasmodium falciparum field isolates

    Article • Scientific Reports, July 2017, Springer Science + Business Media

    James Beeson

  170. Determinants of knowledge of critical danger signs, safe childbirth and immediate newborn care practices among auxiliary midwives: a cross sectional survey in Myanmar

    Article • BMJ Open, June 2017, BMJ

    Minh Pham, James Beeson

  171. Prevention of postpartum haemorrhage by community-based auxiliary midwives in hard-to-reach areas of Myanmar: a qualitative inquiry into acceptability and feasibility of task shifting

    Article • BMC Pregnancy and Childbirth, May 2017, Springer Science + Business Media

    James Beeson

  172. Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum

    Article • American Journal of Tropical Medicine and Hygiene, May 2017, American Society of Tropical Medicine and Hygiene

    Prof Rose McGready, James Beeson

  173. Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort

    Article • Proceedings of the National Academy of Sciences, March 2017, Proceedings of the National Academy of Sciences

    James Beeson

  174. The potential benefit of scaling up malaria prevention to reduce low birth weight in Africa

    Article • PLoS Medicine, February 2017, PLOS

    James Beeson

  175. Plasmodium vivax vaccine research – we’ve only just begun

    Article • International Journal for Parasitology, February 2017, Elsevier

    James Beeson

  176. Inhibition of placental mTOR signaling provides a link between placental malaria and reduced birthweight

    Article • BMC Medicine, January 2017, Springer Science + Business Media

    James Beeson

  177. Truncated Latrunculins as Actin Inhibitors Targeting Plasmodium falciparum Motility and Host Cell Invasion

    Article • Journal of Medicinal Chemistry, December 2016, American Chemical Society (ACS)

    James Beeson

  178. Evaluating Complement-Mediated Humoral Immunity to P. falciparum Blood Stages

    Article • EBioMedicine, December 2016, Elsevier

    James Beeson

  179. Differing rates of antibody acquisition in malaria: implications for immunity and surveillance

    Article • Journal of Leukocyte Biology, November 2016, Wiley

    James Beeson

  180. Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation

    Article • Malaria Journal, November 2016, Springer Science + Business Media

    James Beeson

  181. Functional Antibodies and Protection against Blood-stage Malaria

    Article • Trends in Parasitology, November 2016, Elsevier

    James Beeson

  182. A malaria vaccine in children with HIV

    Article • The Lancet Infectious Diseases, October 2016, Elsevier

    James Beeson

  183. Structure–Activity Studies of β-Hairpin Peptide Inhibitors of the Plasmodium falciparum AMA1–RON2 Interaction

    Article • Journal of Molecular Biology, October 2016, Elsevier

    Professor Martin J Scanlon, James Beeson

  184. A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens

    Article • BMC Medicine, September 2016, Springer Science + Business Media

    James Beeson

  185. Specific antibodies to the PfRH5 invasion complex and protection from malaria

    Article • Scientific Reports, September 2016, Nature

    James Beeson

  186. Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period

    Article • Scientific Reports, August 2016, Nature

    Prof Rose McGready, James Beeson

  187. The global threat of Zika virus to pregnancy: epidemiology, clinical perspectives, mechanisms, and impact

    Article • BMC Medicine, August 2016, Springer Science + Business Media

    Dr Heidi E Drummer, James Beeson

  188. Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite

    Article • Infection and Immunity, July 2016, ASM Journals

    Professor Yaoqi Zhou, James Beeson

  189. A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies

    Article • Cellular and Molecular Life Sciences, May 2016, Springer Science + Business Media

    James Beeson

  190. Merozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity

    Article • Infection and Immunity, May 2016, ASM Journals

    Danika Hill, James Beeson

  191. Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2

    Article • Scientific Reports, February 2016, Springer Science + Business Media

    James Beeson

  192. Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting

    Article • Scientific Reports, February 2016, Nature

    Prof Rose McGready, James Beeson

  193. Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort

    Article • Clinical and Vaccine Immunology, February 2016, ASM Journals

    James Beeson

  194. Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria

    Article • FEMS Microbiology Reviews, January 2016, Oxford University Press (OUP)

    James Beeson

  195. Immunity to malaria in an era of declining malaria transmission

    Article • Parasitology, January 2016, Cambridge University Press

    James Beeson

  196. High resolution FTIR imaging provides automated discrimination and detection of single malaria parasite infected erythrocytes on glass

    Article • Faraday Discussions, January 2016, Royal Society of Chemistry

    James Beeson

  197. Designing malaria vaccines to circumvent antigen variability

    Article • Vaccine, December 2015, Elsevier

    James Beeson

  198. Erratum to: CD14 hi CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so

    Article • BMC Medicine, November 2015, Springer Science + Business Media

    James Beeson

  199. Insights into the Immunological Properties of Intrinsically Disordered Malaria Proteins Using Proteome Scale Predictions

    Article • PLOS One, October 2015, PLOS

    James Beeson

  200. Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya

    Article • EBioMedicine, October 2015, Elsevier

    James Beeson

  201. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases

    Article • Molecular Immunology, October 2015, Elsevier

    James Beeson

  202. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities

    Article • Proceedings of the National Academy of Sciences, July 2015, Proceedings of the National Academy of Sciences

    James Beeson

  203. Malaria eradication and elimination: views on how to translate a vision into reality

    Article • BMC Medicine, July 2015, Springer Science + Business Media

    James Beeson

  204. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum

    Article • BMC Biology, July 2015, Springer Science + Business Media

    Dr Brad E Sleebs, James Beeson

  205. CD14hiCD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so

    Article • BMC Medicine, July 2015, Springer Science + Business Media

    James Beeson

  206. Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens

    Article • BMC Microbiology, July 2015, Springer Science + Business Media

    James Beeson

  207. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection AgainstPlasmodium falciparumMalaria in Children

    Article • Clinical Infectious Diseases, July 2015, Oxford University Press (OUP)

    James Beeson

  208. The impact of lipid-based nutrient supplementation on anti-malarial antibodies in pregnant women in a randomized controlled trial

    Article • Malaria Journal, May 2015, Springer Science + Business Media

    James Beeson

  209. Maximizing antimalarial efficacy and the importance of dosing strategies

    Article • BMC Medicine, May 2015, Springer Science + Business Media

    James Beeson

  210. Plasmodium vivax Malaria

    Article • The Pediatric Infectious Disease Journal, May 2015, Wolters Kluwer Health

    James Beeson

  211. Risk factors for malaria and adverse birth outcomes in a prospective cohort of pregnant women resident in a high malaria transmission area of Papua New Guinea

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, March 2015, Oxford University Press (OUP)

    James Beeson

  212. Conformational Dynamics and Antigenicity in the Disordered Malaria Antigen Merozoite Surface Protein 2

    Article • PLOS One, March 2015, PLOS

    James Beeson

  213. Malaria and immunity during pregnancy and postpartum: a tale of two species

    Article • Parasitology, March 2015, Cambridge University Press

    James Beeson

  214. Human Antibodies Fix Complement to Inhibit Plasmodium falciparum Invasion of Erythrocytes and Are Associated with Protection against Malaria

    Article • Immunity, March 2015, Elsevier

    James Beeson

  215. PfRH5 as a candidate vaccine for Plasmodium falciparum malaria

    Article • Trends in Parasitology, March 2015, Elsevier

    James Beeson

  216. Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response

    Article • Infection and Immunity, November 2014, ASM Journals

    James Beeson

  217. Research priorities for the development and implementation of serological tools for malaria surveillance

    Article • F1000Prime Reports, November 2014, Faculty of 1000, Ltd.

    James Beeson

  218. Limited antigenic diversity of Plasmodium falciparumapical membrane antigen 1 supports the development of effective multi-allele vaccines

    Article • BMC Medicine, October 2014, Springer Science + Business Media

    Dr Alyssa Barry, James Beeson

  219. Immunological markers of Plasmodium vivaxexposure and immunity: a systematic review and meta-analysis

    Article • BMC Medicine, September 2014, Springer Science + Business Media

    James Beeson

  220. Use of Immunodampening To Overcome Diversity in the Malarial Vaccine Candidate Apical Membrane Antigen 1

    Article • Infection and Immunity, August 2014, ASM Journals

    James Beeson

  221. PTEX is an essential nexus for protein export in malaria parasites

    Article • Nature, July 2014, Nature

    Dr Philip J. Shaw, James Beeson

  222. Opsonic phagocytosis of Plasmodium falciparummerozoites: mechanism in human immunity and a correlate of protection against malaria

    Article • BMC Medicine, July 2014, Springer Science + Business Media

    James Beeson

  223. Decreasing Malaria Prevalence and Its Potential Consequences for Immunity in Pregnant Women

    Article • The Journal of Infectious Diseases, May 2014, Oxford University Press (OUP)

    James Beeson

  224. Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates

    Article • Cellular and Molecular Life Sciences, April 2014, Springer Science + Business Media

    James Beeson

  225. A critical evaluation of pyrrolo[2,3-d]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors

    Article • MedChemComm, January 2014, Royal Society of Chemistry

    Dr Shane M Devine, Professor Martin J Scanlon, James Beeson

  226. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria

    Article • Malaria Journal, January 2014, Springer Science + Business Media

    James Beeson

  227. Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1

    Article • PLoS Pathogens, December 2013, PLOS

    James Beeson

  228. Sequential Processing of Merozoite Surface Proteins during and after Erythrocyte Invasion by Plasmodium falciparum

    Article • Infection and Immunity, November 2013, ASM Journals

    James Beeson

  229. Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines

    Article • BMC Medicine, October 2013, Springer Science + Business Media

    James Beeson

  230. Antibodies to Polymorphic Invasion-Inhibitory and Non-Inhibitory Epitopes of Plasmodium falciparum Apical Membrane Antigen 1 in Human Malaria

    Article • PLOS One, July 2013, PLOS

    James Beeson

  231. Erythrocyte-Binding Antigens ofPlasmodium falciparumAre Targets of Human Inhibitory Antibodies and Function To Evade Naturally Acquired Immunity

    Article • The Journal of Immunology, July 2013, Oxford University Press (OUP)

    James Beeson

  232. Identification and Prioritization of Merozoite Antigens as Targets of Protective Human Immunity to Plasmodium falciparum Malaria for Vaccine and Biomarker Development

    Article • The Journal of Immunology, July 2013, Oxford University Press (OUP)

    James Beeson

  233. Acquired Antibodies to Merozoite Antigens in Children from Uganda with Uncomplicated or Severe Plasmodium falciparum Malaria

    Article • Clinical and Vaccine Immunology, June 2013, ASM Journals

    James Beeson

  234. Reply to Eisenhut

    Article • The Journal of Infectious Diseases, May 2013, Oxford University Press (OUP)

    James Beeson

  235. PfEMP1 as a target of human immunity and a vaccine candidate against malaria

    Article • Expert Review of Vaccines, February 2013, Taylor & Francis

    James Beeson

  236. Does Malaria Affect Placental Development? Evidence from In Vitro Models

    Article • PLOS One, January 2013, PLOS

    James Beeson

  237. Defining the Timing of Action of Antimalarial Drugs against Plasmodium falciparum

    Article • Antimicrobial Agents and Chemotherapy, January 2013, ASM Journals

    James Beeson

  238. New approaches to studying Plasmodium falciparum merozoite invasion and insights into invasion biology

    Article • International Journal for Parasitology, January 2013, Elsevier

    James Beeson

  239. Platelet Factor 4 and Duffy Antigen Required for Platelet Killing of Plasmodium falciparum

    Article • Science, December 2012, American Association for the Advancement of Science

    James Beeson

  240. Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria

    Article • PLOS One, December 2012, PLOS

    James Beeson

  241. Antibody Boosting and Longevity Following Tetanus Immunization During Pregnancy

    Article • Clinical Infectious Diseases, November 2012, Oxford University Press (OUP)

    Prof Rose McGready, James Beeson

  242. The Plasmodium falciparum Erythrocyte Invasion Ligand Pfrh4 as a Target of Functional and Protective Human Antibodies against Malaria

    Article • PLOS One, September 2012, PLOS

    Dr Alyssa Barry, James Beeson

  243. Antigenic Characterization of an Intrinsically Unstructured Protein, Plasmodium falciparum Merozoite Surface Protein 2

    Article • Infection and Immunity, September 2012, ASM Journals

    James Beeson

  244. New Insights into Acquisition, Boosting, and Longevity of Immunity to Malaria in Pregnant Women

    Article • The Journal of Infectious Diseases, September 2012, Oxford University Press (OUP)

    Prof Rose McGready, James Beeson

  245. Targets of antibodies against Plasmodium falciparum–infected erythrocytes in malaria immunity

    Article • Journal of Clinical Investigation, September 2012, American Society for Clinical Investigation

    James Beeson

  246. Malaria Parasite Signal Peptide Peptidase is an ER‐Resident Protease Required for Growth but not for Invasion

    Article • Traffic, August 2012, Wiley

    James Beeson

  247. Plasmodium vivax Adherence to Placental Glycosaminoglycans

    Article • PLOS One, April 2012, PLOS

    James Beeson

  248. Perspectives: The missing pieces

    Article • Nature, April 2012, Springer Science + Business Media

    Professor David A Fidock, James Beeson

  249. Intermittent Preventive Treatment for Malaria in Papua New Guinean Infants Exposed to Plasmodium falciparum and P. vivax: A Randomized Controlled Trial

    Article • PLoS Medicine, March 2012, PLOS

    James Beeson

  250. High Affinity Antibodies to Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Malaria

    Article • PLOS One, February 2012, PLOS

    James Beeson

  251. Antibody to P. falciparum in Pregnancy Varies with Intermittent Preventive Treatment Regime and Bed Net Use

    Article • PLOS One, January 2012, PLOS

    James Beeson

  252. Quantifying the Importance of MSP1-19 as a Target of Growth-Inhibitory and Protective Antibodies against Plasmodium falciparum in Humans

    Article • PLOS One, November 2011, PLOS

    James Beeson

  253. A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720

    Article • PLOS One, September 2011, PLOS

    James Beeson

  254. Discovery of GAMA, a Plasmodium falciparum Merozoite Micronemal Protein, as a Novel Blood-Stage Vaccine Candidate Antigen

    Article • Infection and Immunity, September 2011, ASM Journals

    James Beeson

  255. IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamine

    Article • Immunobiology, July 2011, Elsevier

    James Beeson

  256. Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite Isolates

    Article • PLOS One, February 2011, PLOS

    Dr Benoit Gamain, James Beeson

  257. Intermittent Preventive Treatment to Reduce the Burden of Malaria in Children: New Evidence on Integration and Delivery

    Article • PLoS Medicine, February 2011, PLOS

    James Beeson

  258. Placental Malaria-Associated Inflammation Disturbs the Insulin-like Growth Factor Axis of Fetal Growth Regulation

    Article • The Journal of Infectious Diseases, January 2011, Oxford University Press (OUP)

    James Beeson

  259. Super-Resolution Dissection of Coordinated Events during Malaria Parasite Invasion of the Human Erythrocyte

    Article • Cell Host & Microbe, January 2011, Elsevier

    Associate Professor Cynthia B Whitchurch, James Beeson

  260. Reticulocyte and Erythrocyte Binding-Like Proteins Function Cooperatively in Invasion of Human Erythrocytes by Malaria Parasites

    Article • Infection and Immunity, December 2010, ASM Journals

    James Beeson

  261. Evidence That the Erythrocyte Invasion Ligand PfRh2 is a Target of Protective Immunity against Plasmodium falciparum Malaria

    Article • The Journal of Immunology, November 2010, Oxford University Press (OUP)

    James Beeson

  262. Stepwise dissection of Plasmodium falciparum merozoite invasion of the human erythrocyte

    Article • Malaria Journal, October 2010, Springer Science + Business Media

    Associate Professor Cynthia B Whitchurch, James Beeson

  263. Association between Naturally Acquired Antibodies to Erythrocyte‐Binding Antigens ofPlasmodium falciparumand Protection from Malaria and High‐Density Parasitemia

    Article • Clinical Infectious Diseases, October 2010, Oxford University Press (OUP)

    James Beeson

  264. Minimal Association of Common Red Blood Cell Polymorphisms with Plasmodium falciparum Infection and Uncomplicated Malaria in Papua New Guinean School Children

    Article • American Journal of Tropical Medicine and Hygiene, October 2010, American Society of Tropical Medicine and Hygiene

    James Beeson

  265. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand

    Article • Proceedings of the National Academy of Sciences, September 2010, Proceedings of the National Academy of Sciences

    James Beeson

  266. Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development

    Article • Proceedings of the National Academy of Sciences, July 2010, Proceedings of the National Academy of Sciences

    James Beeson

  267. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites

    Article • Blood, June 2010, American Society of Hematology

    James Beeson

  268. Using an Improved Phagocytosis Assay to Evaluate the Effect of HIV on Specific Antibodies to Pregnancy-Associated Malaria

    Article • PLOS One, May 2010, PLOS

    James Beeson

  269. Antibodies to Chondroitin Sulfate A–Binding Infected Erythrocytes: Dynamics and Protection during Pregnancy in Women Receiving Intermittent Preventive Treatment

    Article • The Journal of Infectious Diseases, May 2010, Oxford University Press (OUP)

    James Beeson

  270. Immunization with VAR2CSA-DBL5 Recombinant Protein Elicits Broadly Cross-Reactive Antibodies to Placental Plasmodium falciparum-Infected Erythrocytes

    Article • Infection and Immunity, March 2010, ASM Journals

    James Beeson

  271. Evaluation of the Antigenic Diversity of Placenta-Binding Plasmodium falciparum Variants and the Antibody Repertoire among Pregnant Women

    Article • Infection and Immunity, February 2010, ASM Journals

    James Beeson

  272. The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis

    Article • PLoS Medicine, January 2010, PLOS

    James Beeson

  273. Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays

    Article • Malaria Journal, January 2010, Springer Science + Business Media

    James Beeson

  274. Strain-Specific Duffy Binding Protein Antibodies Correlate with Protection against Infection with Homologous Compared to Heterologous Plasmodium vivax Strains in Papua New Guinean Children

    Article • Infection and Immunity, June 2009, ASM Journals

    James Beeson

  275. The future for blood‐stage vaccines against malaria

    Article • Immunology and Cell Biology, May 2009, Wiley

    James Beeson

  276. Cellular Tumor Necrosis Factor, Gamma Interferon, and Interleukin-6 Responses as Correlates of Immunity and Risk of Clinical Plasmodium falciparum Malaria in Children from Papua New Guinea

    Article • Infection and Immunity, April 2009, ASM Journals

    James Beeson

  277. Sir2 Paralogues Cooperate to Regulate Virulence Genes and Antigenic Variation in Plasmodium falciparum

    Article • PLoS Biology, April 2009, PLOS

    James Beeson

  278. Antibodies to Reticulocyte Binding Protein-Like Homologue 4 Inhibit Invasion of Plasmodium falciparum into Human Erythrocytes

    Article • Infection and Immunity, March 2009, ASM Journals

    James Beeson

  279. Reticulocyte-binding protein homologue 5 – An essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum

    Article • International Journal for Parasitology, February 2009, Elsevier

    James Beeson

  280. Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness

    Article • Infection and Immunity, January 2009, ASM Journals

    James Beeson

  281. Analysis of structure and function of the giant protein Pf332 in Plasmodium falciparum

    Article • Molecular Microbiology, December 2008, Wiley

    James Beeson

  282. Recent insights into humoral and cellular immune responses against malaria

    Article • Trends in Parasitology, December 2008, Elsevier

    James Beeson

  283. Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum

    Article • PLOS One, October 2008, PLOS

    James Beeson

  284. Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults

    Article • PLOS One, October 2008, PLOS

    James Beeson

  285. Exported Proteins Required for Virulence and Rigidity of Plasmodium falciparum-Infected Human Erythrocytes

    Article • Cell, July 2008, Elsevier

    James Beeson

  286. Estimating the Burden of Global Mortality in Children Aged <5 Years by Pathogen‐Specific Causes

    Article • Clinical Infectious Diseases, June 2008, Oxford University Press (OUP)

    James Beeson

  287. Characteristics of Plasmodium falciparum-Infected-Erythrocyte Adhesion to Chondroitin Sulfate

    Article • Infection and Immunity, May 2008, ASM Journals

    James Beeson

  288. Polymorphic and Conserved Targets of Antibodies againstPlasmodium falciparumduring Pregnancy

    Article • The Journal of Infectious Diseases, May 2008, Oxford University Press (OUP)

    James Beeson

  289. Truncation of Plasmodium berghei merozoite surface protein 8 does not affect in vivo blood-stage development

    Article • Molecular and Biochemical Parasitology, May 2008, Elsevier

    James Beeson

  290. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies

    Article • Journal of Clinical Investigation, January 2008, American Society for Clinical Investigation

    James Beeson

  291. Characterization of VAR2CSA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line

    Article • Malaria Journal, January 2008, Springer Science + Business Media

    A/Prof Kathy T Andrews, James Beeson

  292. Towards a Vaccine against Plasmodium vivax Malaria

    Article • PLoS Medicine, December 2007, PLOS

    James Beeson

  293. Structural Basis for Binding of Plasmodium falciparum Erythrocyte Membrane Protein 1 to Chondroitin Sulfate and Placental Tissue and the Influence of Protein Polymorphisms on Binding Specificity

    Article • Journal of Biological Chemistry, August 2007, Elsevier

    James Beeson

  294. Serum Lipoproteins Promote Efficient Presentation of the Malaria Virulence Protein PfEMP1 at the Erythrocyte Surface

    Article • Eukaryotic Cell, July 2007, ASM Journals

    James Beeson

  295. Antibodies among Men and Children to Placental-Binding Plasmodium falciparum-Infected Erythrocytes that Express var2csa

    Article • American Journal of Tropical Medicine and Hygiene, July 2007, American Society of Tropical Medicine and Hygiene

    James Beeson

  296. THE RISK OF MALARIAL INFECTIONS AND DISEASE IN PAPUA NEW GUINEAN CHILDREN

    Article • American Journal of Tropical Medicine and Hygiene, June 2007, American Society of Tropical Medicine and Hygiene

    James Beeson

  297. Skeleton-binding protein 1 functions at the parasitophorous vacuole membrane to traffic PfEMP1 to the Plasmodium falciparum–infected erythrocyte surface

    Article • Blood, October 2006, American Society of Hematology

    James Beeson

  298. Development and Optimization of High-Throughput Methods To Measure Plasmodium falciparum-Specific Growth Inhibitory Antibodies

    Article • Journal of Clinical Microbiology, May 2006, ASM Journals

    James Beeson

  299. Antigenic Differences and Conservation among PlacentalPlasmodium falciparum–Infected Erythrocytes and Acquisition of Variant‐Specific and Cross‐Reactive Antibodies

    Article • The Journal of Infectious Diseases, March 2006, Oxford University Press (OUP)

    James Beeson

  300. A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria

    Article • Nature, December 2005, Springer Science + Business Media

    James Beeson

  301. Promising Functional Readouts of Immunity in a Blood-Stage Malaria Vaccine Trial

    Article • PLoS Medicine, November 2005, PLOS

    James Beeson

  302. Targets of Protective Antibodies to Malaria during Pregnancy

    Article • The Journal of Infectious Diseases, November 2005, Oxford University Press (OUP)

    James Beeson

  303. Placental Malaria Induces Variant-Specific Antibodies of the Cytophilic Subtypes Immunoglobulin G1 (IgG1) and IgG3 That Correlate with Adhesion Inhibitory Activity

    Article • Infection and Immunity, September 2005, ASM Journals

    James Beeson

  304. Cross-Reactive Surface Epitopes on Chondroitin Sulfate A-Adherent Plasmodium falciparum-Infected Erythrocytes Are Associated with Transcription of var2csa

    Article • Infection and Immunity, May 2005, ASM Journals

    James Beeson

  305. Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype

    Article • Molecular Microbiology, March 2005, Wiley

    James Beeson

  306. The Immunology and Pathogenesis of Malaria During Pregnancy

    Article • January 2005, Springer Science + Business Media

    James Beeson

  307. Clinical features and pathogenesis of severe malaria

    Article • Trends in Parasitology, December 2004, Elsevier

    James Beeson

  308. Malaria in pregnancy and the endemicity spectrum: what can we learn?

    Article • Trends in Parasitology, September 2004, Elsevier

    Prof Rose McGready, James Beeson

  309. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection

    Article • The Lancet, June 2004, Elsevier

    James Beeson

  310. Phenotypes of Plasmodium falciparum from the Peripheral Blood of Pregnant Women

    Article • Infection and Immunity, February 2004, ASM Journals

    James Beeson

  311. Antibodies to Variant Surface Antigens ofPlasmodium falciparum–Infected Erythrocytes and Adhesion Inhibitory Antibodies Are Associated with Placental Malaria and Have Overlapping and Distinct Targets

    Article • The Journal of Infectious Diseases, February 2004, Oxford University Press (OUP)

    James Beeson

  312. Plasmodium falciparum–Infected Erythrocytes Demonstrate Dual Specificity for Adhesion to Hyaluronic Acid and Chondroitin Sulfate A and Have Distinct Adhesive Properties

    Article • The Journal of Infectious Diseases, January 2004, Oxford University Press (OUP)

    James Beeson

  313. An alternative agglutination assay to measure antibodies to variant surfaceantigens of Plasmodium falciparum-infected erythrocytes

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, November 2003, Oxford University Press (OUP)

    James Beeson

  314. Selective Accumulation of Mature Asexual Stages of Plasmodium falciparum-Infected Erythrocytes in the Placenta

    Article • Infection and Immunity, October 2002, ASM Journals

    James Beeson

  315. Evaluating specific adhesion of Plasmodium falciparum-infected erythrocytes to immobilised hyaluronic acid with comparison to binding of mammalian cells

    Article • International Journal for Parasitology, September 2002, Elsevier

    James Beeson

  316. The Structural Motif in Chondroitin Sulfate for Adhesion ofPlasmodium falciparum-infected Erythrocytes Comprises Disaccharide Units of 4-O-Sulfated and Non-sulfated N-Acetylgalactosamine Linked to Glucuronic Acid

    Article • Journal of Biological Chemistry, June 2002, Elsevier

    James Beeson

  317. Expanding the paradigms of placental malaria

    Article • Trends in Parasitology, April 2002, Elsevier

    James Beeson

  318. Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation

    Article • Cellular and Molecular Life Sciences, February 2002, Springer Science + Business Media

    James Beeson

  319. Parasite adhesion and immune evasion in placental malaria

    Article • Trends in Parasitology, July 2001, Elsevier

    James Beeson

  320. Sticky rings: challenging the cytoadherence dogma

    Article • Trends in Parasitology, February 2001, Elsevier

    James Beeson

  321. New agents to combat malaria

    Article • Nature Medicine, February 2001, Springer Science + Business Media

    James Beeson

  322. Inhibition of Adhesion of Plasmodium falciparum-Infected Erythrocytes by Structurally Defined Hyaluronic Acid Dodecasaccharides

    Article • Infection and Immunity, January 2001, ASM Journals

    James Beeson

  323. Identification of Glycosaminoglycan Binding Domains in Plasmodium falciparum Erythrocyte Membrane Protein 1 of a Chondroitin Sulfate A-Adherent Parasite

    Article • Infection and Immunity, July 2000, ASM Journals

    James Beeson

  324. Plasmodium falciparum Rosette Formation Is Uncommon in Isolates from Pregnant Women

    Article • Infection and Immunity, January 2000, ASM Journals

    James Beeson

  325. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria

    Article • Nature Medicine, January 2000, Springer Science + Business Media

    James Beeson

  326. The placenta in malaria: mechanisms of infection, disease and foetal morbidity

    Article • Annals of Tropical Medicine and Parasitology, December 1999, Taylor & Francis

    James Beeson

  327. The placenta in malaria: mechanisms of infection, disease and foetal morbidity

    Article • Annals of Tropical Medicine and Parasitology, December 1999, Taylor & Francis

    James Beeson

  328. Plasmodium falciparumIsolates from Infected Pregnant Women and Children Are Associated with Distinct Adhesive and Antigenic Properties

    Article • The Journal of Infectious Diseases, August 1999, Oxford University Press (OUP)

    James Beeson

  329. The adhesion ofPlasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated byP. falciparumerythrocyte membrane protein 1

    Article • Proceedings of the National Academy of Sciences, April 1999, Proceedings of the National Academy of Sciences

    James Beeson

  330. Inhibition of Binding of Malaria-Infected Erythrocytes by a Tetradecasaccharide Fraction from Chondroitin Sulfate A

    Article • Infection and Immunity, July 1998, ASM Journals

    James Beeson

  331. Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain

    Article • The Journal of Comparative Neurology, April 1994, Wiley

    James Beeson

  332. Differential distribution of amyloid protein precursor immunoreactivity in the rat brain studied by using five different antibodies

    Article • The Journal of Comparative Neurology, April 1994, Wiley

    James Beeson

  333. Synthesis and transacylating reactivity of β-cyclodextrin ethylenediamines

    Article • Bioorganic & Medicinal Chemistry, April 1994, Elsevier

    James Beeson